Fundraising FoxMubadala Capital — 2024 Investments
7 investments dated 2024 · listed companies and verified rows first · show all
Arbol provides parametric insurance products that pay out based on objective third-party climate data after qualifying events, covering specific climate risks for clients ranging from smallholder farmers to large corporations.
AI & Machine LearningClimate TechInsurTech
Siddhartha Jha(Founder)in
Co-investorsGiant Ventures Global LlpOpen Field CapitalOpera Tech Ventures
OpenGDP is an operating layer for real-world economic execution that unifies money, assets, and autonomous systems with institutional-grade controls, security, and speed for enterprises, institutions, and governments.
Crypto & Web3Enterprise SoftwareFintech
BoardNaval Ravikant(Founder, AngelList)Anthony Pompliano(Founder, Pomp Investments)Santiago Roel Santos(Founder, Inversion Capital)Nikil Viswanathan(Co-founder & CEO, Alchemy)Joe Lau(Co-founder & CTO, Alchemy)
Co-investorsCoinbase VenturesPantera CapitalAnthony PomplianoBain Capital VenturesDigital Currency GroupFramework Ventures+7 more
Metsera was a clinical-stage biotechnology company developing injectable and oral medicines for obesity and metabolic diseases, including next-generation GLP-1 and amylin-based therapies.
BiotechHealthtechMedical DevicesNew York, US
Clive A. Meanwell(Director)Christopher J. Visioli(Executive Officer)inBrian Hubbard(Executive Officer)inChristopher Whitten Bernard(Executive Officer, Director)Steven Marso(Executive Officer)Clive Meanwell(Founder)
Co-investorsAlpha Wave GlobalARCH Venture PartnersF-Prime CapitalGV (Google Ventures)RA CapitalSoftBank Vision Fund+5 more
nChroma Bio develops in vivo targeted delivery and genetic engineering technologies for genetic medicine applications.
BiotechDeep TechMedical DevicesBoston, US
Luke Gilbert, PhD(Founder)Keith Joung, MD, PhD(Founder)David Liu, PhD(Founder)Angelo Lombardo, PhD(Founder)Luigi Naldini, MD, PhD(Founder)Jonathan Weissman, PhD
Co-investorsAtlas VentureNewpath Partners5AM VenturesARCH Venture PartnersDCVC (Data Collective)F-Prime Capital+11 more
Outpace Bio develops engineered protein technologies and cell therapies to treat solid tumors, focusing on protein design and T cell engineering to improve cancer treatment efficacy and safety.
BiotechDeep TechMedical DevicesSeattle, US
Marc Lajoie(Founder)inScott Boyken(Founder)inStanley Riddell(Co-Founder and Scientific Advisor)Aaron Foster(Executive Officer)inCharity Scripture(Executive Officer)inEric Soller(Executive Officer)in
Co-investorsArtis VenturesRA CapitalAbstract VenturesATEL VenturesAtinum Investment Co. Ltd.Civilization Ventures Management, Llc+9 more
Parametric builds software for physical businesses to operate autonomously.
Advanced ManufacturingEnterprise SoftwareRoboticsSaaSSan Francisco, US
Cody Swain(CEO)inJohn Newsom(CTO)inKiyana Okayasu(Executive Assistant)John Alvarez(Founding Software Engineer)Kyle Haynes(Staff Mechanical Engineer)Lucas Czajka(Operations)
Co-investorsSwell PartnersY CombinatorMana VenturesOpera Tech VenturesOrange DAOSpace Capital
Storyblok develops a headless content management system (CMS) that helps developer and marketing teams build and manage digital content and experiences.
Developer ToolsMarketing TechSaaS
Dominik Angerer(Founder)inAlexander Feiglstorfer
Co-investors3VCAtlantic Bridge VenturesBrighton Park CapitalDragon Capitalfirstminute capitalFounders Factory+4 more
.jpeg){kind=logo}
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.